Iovance Biotherapeutics Intangible Assets

Iovance Biotherapeutics (IOVA) currently reports a intangible assets of $270M as of March 2026. That compares with $290M in the prior-year period — down 5.7% year over year. Use the charts on this page to explore Iovance Biotherapeutics's intangible assets history and peer comparisons.

Iovance Biotherapeutics's intangible assets decreased from $290M to $270M — a 5.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Iovance Biotherapeutics reported $270M in intangible assets as of March 2026. That compares with $290M in the prior-year period — down 5.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $270M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Iovance Biotherapeutics, and consider following IOVA for alerts when major investors trade the stock.

Iovance Biotherapeutics is classified in the Healthcare sector. On intangible assets, it currently shows $270M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IOVA with unrelated industries.